NEWS
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Top Lists
Carl Kirkpatrick
Monash University - Clayton / Australia
Others
AD Scientific Index ID: 119792
Monash University
Edit Form
Registration, Add Profile,
Premium Membership
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Carl Kirkpatrick's MOST POPULAR ARTICLES
1-)
Clinical pharmacokinetics of metforminGG Graham, J Punt, M Arora, RO Day, MP Doogue, J Duong, TJ Furlong, ...Clinical pharmacokinetics 50 (2), 81-98, 201111752011
2-)
Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children—a meta-analysisJF Roos, J Doust, SE Tett, CMJ KirkpatrickClinical biochemistry 40 (5-6), 383-391, 20075682007
3-)
Prevalence and factors associated with polypharmacy in long-term care facilities: a systematic reviewN Jokanovic, ECK Tan, MJ Dooley, CM Kirkpatrick, JS BellJournal of the American Medical Directors Association 16 (6), 535. e1-535. e12, 20153572015
4-)
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and …JA Roberts, CMJ Kirkpatrick, MS Roberts, TA Robertson, AJ Dalley, ...Journal of antimicrobial chemotherapy 64 (1), 142-150, 20093852009
5-)
Resveratrol does not benefit patients with nonalcoholic fatty liver diseaseVS Chachay, GA Macdonald, JH Martin, JP Whitehead, ...Clinical Gastroenterology and Hepatology 12 (12), 2092-2103. e6, 20143062014
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept